113 related articles for article (PubMed ID: 22890319)
1. Hepatocyte odd protein shuttling (HOPS) is a bridging protein in the nucleophosmin-p19 Arf network.
Castelli M; Pieroni S; Brunacci C; Piobbico D; Bartoli D; Bellet MM; Colombo E; Pelicci PG; Della Fazia MA; Servillo G
Oncogene; 2013 Jul; 32(28):3350-8. PubMed ID: 22890319
[TBL] [Abstract][Full Text] [Related]
2. The Ins and Outs of HOPS/TMUB1 in biology and pathology.
Della-Fazia MA; Castelli M; Piobbico D; Pieroni S; Servillo G
FEBS J; 2021 May; 288(9):2773-2783. PubMed ID: 32860479
[TBL] [Abstract][Full Text] [Related]
3. Different functions of HOPS isoforms in the cell: HOPS shuttling isoform is determined by RIP cleavage system.
Castelli M; Piobbico D; Bartoli D; Pieroni S; Brunacci C; Bellet MM; Chiacchiaretta M; Della Fazia MA; Servillo G
Cell Cycle; 2014; 13(2):293-302. PubMed ID: 24240191
[TBL] [Abstract][Full Text] [Related]
4. Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3.
Kuo ML; den Besten W; Thomas MC; Sherr CJ
Cell Cycle; 2008 Nov; 7(21):3378-87. PubMed ID: 18948745
[TBL] [Abstract][Full Text] [Related]
5. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
[TBL] [Abstract][Full Text] [Related]
6. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
[TBL] [Abstract][Full Text] [Related]
7. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.
Bertwistle D; Sugimoto M; Sherr CJ
Mol Cell Biol; 2004 Feb; 24(3):985-96. PubMed ID: 14729947
[TBL] [Abstract][Full Text] [Related]
8. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.
Tao W; Levine AJ
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6937-41. PubMed ID: 10359817
[TBL] [Abstract][Full Text] [Related]
9. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
10. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.
Brady SN; Yu Y; Maggi LB; Weber JD
Mol Cell Biol; 2004 Nov; 24(21):9327-38. PubMed ID: 15485902
[TBL] [Abstract][Full Text] [Related]
11. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
[TBL] [Abstract][Full Text] [Related]
12. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
den Besten W; Kuo ML; Williams RT; Sherr CJ
Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
[TBL] [Abstract][Full Text] [Related]
13. HOPS and p53: thick as thieves in life and death.
Della-Fazia MA; Castelli M; Piobbico D; Pieroni S; Servillo G
Cell Cycle; 2020 Nov; 19(22):2996-3003. PubMed ID: 33112208
[TBL] [Abstract][Full Text] [Related]
14. Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.
Brady SN; Maggi LB; Winkeler CL; Toso EA; Gwinn AS; Pelletier CL; Weber JD
Oncogene; 2009 Sep; 28(36):3209-20. PubMed ID: 19561638
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
[TBL] [Abstract][Full Text] [Related]
16. DNA damage-dependent translocation of B23 and p19 ARF is regulated by the Jun N-terminal kinase pathway.
Yogev O; Saadon K; Anzi S; Inoue K; Shaulian E
Cancer Res; 2008 Mar; 68(5):1398-406. PubMed ID: 18316603
[TBL] [Abstract][Full Text] [Related]
17. The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence.
Cheng K; Grisendi S; Clohessy JG; Majid S; Bernardi R; Sportoletti P; Pandolfi PP
Oncogene; 2007 Nov; 26(53):7391-400. PubMed ID: 17546053
[TBL] [Abstract][Full Text] [Related]
18. Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53.
Moulin S; Llanos S; Kim SH; Peters G
Oncogene; 2008 Apr; 27(17):2382-9. PubMed ID: 17968318
[TBL] [Abstract][Full Text] [Related]
19. Reactivating the ARF-p53 axis in AML cells by targeting ULF.
Chen D; Yoon JB; Gu W
Cell Cycle; 2010 Aug; 9(15):2946-51. PubMed ID: 20699639
[TBL] [Abstract][Full Text] [Related]
20. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
